Stocks
Aerie Pharmaceuticals (AERI) EBITDA margin US GAAP (year values) |
|||||||||
| FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -941.2% | -238.0% | -141.0% | -3.49% | -0.59% | |||
| Changes by years, y/y, % | +703pp | +97pp | +138pp | -84.5% | |||||
Aerie Pharmaceuticals. EBITDA margin, %
Aerie Pharmaceuticals. EBITDA margin, changes, pp
Aerie Pharmaceuticals (AERI) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2021Q3 | FY2021Q4 | FY2022Q1 | FY2022Q2 | FY2022Q3 | LTM ? | |||
| EBITDA margin, % | ? | -77.3% | 56.8% | -100.4% | -44.2% | -60.2% | -0.59% | |
| Changes by years, y/y, % | +44pp | +158pp | +13pp | +38pp | +17pp | |||
| Changes by quarters, q/q, % | +5pp | +134pp | -157pp | +56pp | -16pp | |||
